What Happens to Your 7-OH Kratom Inventory After August 5?
The DEA can't schedule concentrated 7-OH before August 5, 2026 — but it can act any day after that. Here's the exact threshold, the timeline, and what wholesale buyers and retailers should already be doing with their shelves.
As of today, concentrated 7-hydroxymitragynine (7-OH) is not yet a federally scheduled substance. On July 1, 2026, DEA announced it intends to temporarily place 7-OH above a set threshold, plus three related synthetic compounds, into Schedule I of the Controlled Substances Act. The Federal Register notice is explicit: the order will not be issued before August 5, 2026. When it is issued, it takes effect the day it's published — not 30 days later — and it applies to concentrated, isolated, and semi-synthetic 7-OH products, not to ordinary botanical kratom leaf below the threshold. If you carry 7-OH SKUs, the work to do is between now and publication day, not after it.
How We Got to August 5
This isn't a snap decision. The scheduling push has been building since 2025, and the current 30-day statutory window is the last formal step before DEA can act.
FDA flags concentrated 7-OH to DEA and issues warning letters to firms marketing 7-OH products as dietary supplements or foods.
DEA transmits its scheduling notice to HHS; HHS responds that it has no objection to temporary Schedule I placement above the proposed threshold.
DEA files two notices of intent: one for 7-OH above threshold, one for three related synthetic alkaloids (mitragynine pseudoindoxyl, MGM-15, MGM-16).
The formal 30-day statutory clock starts. HHS opens a parallel request for information on the proposed threshold and product chemistry.
Over 24,000 comments filed on the docket by the deadline, spanning consumers, retailers, and pain-management advocates.
DEA has said it intends to publish "as soon as possible" after this date. Once published, the order is effective immediately and runs for two years, with a possible one-year extension.
What Actually Changes (And What Doesn't)
The single most common misread of this notice is treating it as a kratom ban. It isn't. The threshold language is written to isolate concentrated and synthetic material from the plant itself.
Botanical kratom leaf & powder
- Whole-leaf kratom powder, capsules, and teas below 0.050% 7-OH on a dry-weight basis
- Standard mitragynine content at naturally occurring levels
- Products already compliant with existing FDA food/supplement rules
Concentrated & synthetic 7-OH
- 7-OH shots, tablets, and extracts above 0.050% by weight/volume or 1.00mg per unit
- Isolated or lab-enhanced 7-OH products
- Mitragynine pseudoindoxyl, MGM-15, and MGM-16, regardless of concentration
Why the fourth compound matters: DEA hasn't found evidence of active consumer sales of MGM-16 yet, but flagged a vendor already listing it for future sale — scheduling it now, alongside MGM-15, is meant to close that loophole before it opens.
Threshold Compliance Reference
Match your SKU's lab data against the proposed federal threshold below. This is a plain-language screening reference for internal triage, not a substitute for your COA or legal counsel.
| Product Type | Threshold | Verdict If Exceeded |
|---|---|---|
| Botanical leaf / powder | > 0.050% 7-OH, dry weight basis | Above Threshold |
|
Concentrate, shot, tablet, or extract |
> 0.050% by weight/volume, or > 1.00mg per unit | Above Threshold |
|
Isolated or synthetic 7-OH / MP / MGM-15 / MGM-16 |
Any detectable concentration | Schedule I Risk |
|
Any of the above, below the stated threshold |
— | Below Threshold |
The Inventory Action Matrix
Map your current stock into one of three lanes now, while you still have time to act deliberately instead of reactively.
| Inventory Lane | Current Status | Recommended Action |
|---|---|---|
| Botanical leaf, below threshold | Not named in the notice | Continue normal ordering and sale. Keep current COAs on file in case threshold guidance is refined before final publication. |
| Concentrates near or above threshold | Directly targeted once order publishes | Segregate physically and in your POS system now. Talk to your distributor about return, exchange, or destruction options before publication, not after. |
| Isolated 7-OH, MP, MGM-15, MGM-16 | Directly targeted regardless of concentration | Highest priority for review. These carry the least ambiguity in the notice language — plan for wind-down of these SKUs specifically. |
Once the order publishes, it's effective that day. There is no 30-day grace period built into the order itself — the 30-day clock that already ran was the notice period before DEA could act, not a compliance runway after the order is issued. Retailers who wait to act until they see a headline will be reacting to a rule that's already live.
Frequently Asked Questions
Not yet. The notice of intent isn't a scheduling order. 7-OH above the proposed threshold becomes a Schedule I substance only once DEA actually publishes the order, which cannot happen before August 5, 2026.
More than 0.050% 7-OH on a dry-weight basis for botanical material, or more than 0.050% by weight/volume or 1.00mg per unit for synthetic, isolated, or concentrated forms.
No. The action targets concentrated, isolated, and semi-synthetic 7-OH and three related synthetic compounds. Botanical leaf below the threshold isn't named in the notice.
Two years, with a possible one-year extension if permanent scheduling proceedings are still pending when the two years run out.
Yes, for SKUs at or below the proposed threshold. For anything near or above it, confirm current lab documentation with your supplier before the order ships, not after.
Primary Sources & Further Reading
- Federal Register / DEANotice of intent to temporarily schedule 7-hydroxymitragynine, published July 6, 2026.
- Congressional Research ServiceLegal Sidebar summarizing the statutory timeline and prior kratom regulatory history via Congress.gov.
- GGD GuidesBrowse the full GGD regulatory & compliance guide library for related briefings on vape and nicotine product rules.
- GGD CatalogReview current kratom wholesale inventory and brand directory to cross-check your own SKUs against threshold-compliant stock.
Auditing Your Kratom SKUs Before August 5?
GGD's wholesale team can help you cross-check your current kratom catalog against the proposed threshold and line up compliant replacement stock ahead of any order taking effect.
